Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. - Wikidata - awgldk - TriplyDB

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

http://www.wikidata.org/entity/Q33836636

about

The future of molecular diagnostics for drug-resistant tuberculosis.Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.Diagnostic accuracy of a molecular drug susceptibility testing method for the antituberculosis drug ethambutol: a systematic review and meta-analysis Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo.Tuberculosis chemotherapy: current drug delivery approaches.Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France.Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.Pyrosequencing analysis for mutations in embB codon306 among clinical mycobacterium tuberculosis isolates from Qingdao, China.Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG)Association between embB Codon 306 Mutations, Phenotypic Resistance Profiles, and Genotypic Characterization in Clinical Mycobacterium tuberculosis Isolates from Hebei, China Never take candy from a stranger: the role of the bacterial glycome in host-pathogen interactions.An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol.GenoType® MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale.Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.Single-nucleotide polymorphism in two representative multidrug-resistant Mycobacterium bovis isolates collected from patients in a Spanish hospital harboring a human infection outbreak.STUDY OF PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF MYCOBACTERIUM TUBERCULOSIS ISOLATES RESISTANT TO BOTH ISONIAZID AND ETHAMBUTOL

P2860

Q30455525-0DDF8ECC-D68A-47AB-A656-84B17FCDE3EA Q33559021-D084EEBC-FE8B-46FD-99E2-E84ACCDC4E0E Q34058789-1BCBB9DA-83C7-4201-B692-05AB4663B5C8 Q34596970-99E5FE63-B0B5-456C-B3D1-AF8218845460 Q34648682-90643030-2CFF-418F-94F0-BFDF3988D72D Q34973711-2358BF1E-78B5-41BB-80F1-B40C1CA7A4EE Q35005024-2C625DBA-BF49-48F8-8974-100ACFD6FB81 Q35069271-F893BC4D-E740-4637-B8CD-E11C350E66DF Q35168964-F0890437-43D3-4F61-9F49-6CC365DDEE95 Q35210458-5F97F708-7A7E-4470-89EE-7A39598E63C7 Q35768714-E6744E93-9037-4ECB-AADC-CA195E5E6D67 Q35859945-06FCCEF9-6994-40F1-A3BE-9424E3983996 Q35960725-6F454356-BE49-4BBA-AEAA-AC063F3B020A Q36046598-D4657C99-3553-4BBC-980D-110F8171F309 Q36076037-4E01C876-E79A-4B64-A5D0-78ED5615BE45 Q37081194-CDC6EB24-E88E-4CCC-90B9-FFD9EDD6D8E7 Q37115785-54EBAD1D-B680-47AE-AFDE-43F4E15C34B9 Q37214096-23411ED1-4BC0-4931-B297-29F8E31B015F Q37269089-7B522B9A-41D7-44DA-AC4D-D6CD78474DDD Q37428663-5E7414E8-65B8-4990-B29E-520DBE21055C Q37689721-C02DE1C9-4CFD-4BCE-9D7B-7CEDE62919D0 Q37799461-A0067270-3048-4C5F-8D12-6364401ADB5C Q38898564-040BB9D4-F27D-4F14-BE31-5A3DC41D1735 Q39632553-2F3E7AF2-C357-427C-AC1A-8DB84379BAC6 Q39766083-512FC68C-8CC0-4DDD-8C19-E2DAA2101CEC Q41072559-A4460843-378F-41F9-A0BC-3CEEBF8986CA Q41824901-F1AC4953-6165-4770-AB31-19BDBD8C3E71 Q42062555-7B9E52D4-C504-4532-859D-7C19613F5D89 Q42141102-72097A1B-E562-4242-BABE-903C37F68A5F Q43029354-63608BE5-C8B6-4775-B5B8-E24C830133DF Q57253059-4050B4F3-FF68-471F-8AC1-0189942565DD

P2860

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

http://www.wikidata.org/entity/Q33836636

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@ast

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@en

type

label

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@ast

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@en

prefLabel

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@ast

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@en

P1433

Q33836636-4C299E5E-5CDF-4FC9-8068-B5A0EB5ED005

P1476

Q33836636-2DD9CE8D-3A24-4E86-B852-6AEC04A357E6

P2093

Q33836636-007E342C-C90A-41F5-ABF4-4057B9406332

Q33836636-11B4EF29-EF53-4602-BD09-77B3BB7F0A59

Q33836636-2E976816-FF98-415A-B740-F898EF42B4AC

Q33836636-37D6845A-DEA4-4D79-B46C-88D98EAC1689

Q33836636-3A0FE3D8-443B-41A8-BBDC-44D477B339CE

Q33836636-499963D0-AE64-4C61-9CE0-368BCD53A0F5

Q33836636-67D6E661-CEE8-4F5B-919F-1C39AD6B9DF9

Q33836636-6F6F52DE-013F-485F-BCA7-BF6CB8CF13BD

Q33836636-B5B64A57-FA9F-40BA-9500-6149E2F3A577

Q33836636-E48ACE83-DC26-45CC-9BBD-61FC6F919DC3

P2860

Q33836636-0C19125A-CB9D-4BC1-AA10-5241EAC07978

Q33836636-135F5958-288B-48E5-BA06-F44B4D97D0A6

Q33836636-250476D0-5B6F-4FAE-9DFC-233AD959DA71

Q33836636-25C82E55-992E-4FFC-84DC-AE511689A230

Q33836636-2B7403FB-421E-43E4-8C1D-9826015F14E6

Q33836636-2EF71729-A73C-4895-BB7F-67C0858A4794

Q33836636-342BBE50-630F-4BD3-948C-A9EDB6651F87

Q33836636-363B908F-7081-491A-8BE9-A2164BB94750

Q33836636-373D2D7D-4515-4AC2-BFEB-9B3E87D7D95D

Q33836636-3BE6EC6B-2D99-4504-AD08-6E5A74692DD2

P304

Q33836636-12DDCE65-BC78-4D63-8BC0-569668A08BC3

P31

Q33836636-C21E3960-C161-4AEB-BE0C-1DEA9A5048D2

P356

Q33836636-22FD86B1-26B8-4C77-87BA-AE78BD1DC922

P407

Q33836636-B400EF2D-C6ED-4683-A5B2-91760A2AFFC1

P433

Q33836636-66B646AD-F105-4AC5-99B6-A554BA780D66

P478

Q33836636-EF5C3175-32E7-4141-A789-DA266EAF575D

P577

Q33836636-42837520-0FB6-47C6-A74E-80AB12807F7F

P698

Q33836636-55D337FB-B202-4459-AC3F-54366C98F69B

P921

Q33836636-0BADC8E0-3613-44A2-A02E-ADE1FB7ECBF1

P932

Q33836636-E45F65D8-D600-49A4-B212-86742427C386

P356

AAC.49.6.2218-2225.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Phenotypic and molecular chara ...... both isoniazid and ethambutol.

@en

P2093

Ahmet Sanic

http://www.w3.org/2001/XMLSchema#string

Anne Clobridge

http://www.w3.org/2001/XMLSchema#string

Genet Zickas

http://www.w3.org/2001/XMLSchema#string

Harry W Taber

http://www.w3.org/2001/XMLSchema#string

Jeffrey Driscoll

http://www.w3.org/2001/XMLSchema#string

Jillian Dormandy

http://www.w3.org/2001/XMLSchema#string

Linda M Parsons

http://www.w3.org/2001/XMLSchema#string

Lisa Mirabello

http://www.w3.org/2001/XMLSchema#string

Max Salfinger

http://www.w3.org/2001/XMLSchema#string

Oleg Sinyavskiy

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis

Role of embB in natural and acquired resistance to ethambutol in mycobacteria

Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis

Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia.

P304

2218-2225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.6.2218-2225.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15917515

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

1140517

http://www.w3.org/2001/XMLSchema#string